Arkopharma - Laboratoire pharmaceutique spécialisé dans la phytothérapie
Natural healthcare Products International Finances Science Sustainable development Jobs Contacts
Research & Development | Industrial equipment
Search : 
Go !
| Site map
Additional product licences

New product development

Clinical development

Cosmetic Research & Development
6% of net sales devoted to Research and Development
1,792: the number of product licences held by ARKOPHARMA
100: the number of scientists working in Research and Development
Advance of the product licence portfolio
A Product Licence was obtained in Europe (ACTIVOX Balm in Spain) and 4 registrations in Australia (ARKO-HEALTH WILLOW, BLACK COHOSH and ARTHRO-AID GOLDEN GAIT) and Peru (PHYTO SOYA 35 mg).
Twenty-four Product Licence files were submitted during the second half-year, i.e. 4 in France, 4 in Switzerland, 1 in Spain, 1 in Belgium, 10 in Canada and 4 for general exportation (Australia and Latin America). Moreover, 9 files were completely renewed in Peru.
The big dietetic ranges such as AZINC, PHYTO SOYA and PHYTOBRONZ continue to expand on international markets with many registrations: AZINC OPTIMAL (Morocco, Algeria, Lebanon), AZINC Menopause (Romania), AZINC Pregnancy (Greece), PHYTO BRONZ Intense (Greece, Russia, Baltic countries) and the PHYTO SOYA range, notably PHYTO SOYA Omega-3.
Gamme Phytobronz
Gamme Phytobronz
With regard to cosmetic products, filing activity is still very intense in Russia and the former Soviet Republics, as well as in Asia, where it was crowned by the registration of 10 PLANT SYSTEM range products in China.
Haut de page